Integrated Research Limited (AU:IRI)
ASX:IRI
Want to see AU:IRI full AI Analyst Report?
IRI Stock Chart & Stats
AU$0.34
AU$0.06(14.63%)
At close: 4:00 PM EST
AU$0.34
AU$0.06(14.63%)
Day’s Range― - ―
52-Week RangeAU$0.27 - AU$0.51
Previous CloseN/A
Volume1.25M
Average Volume (3M)387.86K
Market Cap
AU$52.37M
Enterprise ValueAU$12.90M
Total Cash (Recent Filing)AU$43.64M
Total Debt (Recent Filing)AU$2.36M
Price to Earnings (P/E)7.2
Beta0.37
Next Earnings
Aug 19, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield5.97%
Share Statistics
EPS (TTM)0.04
Shares Outstanding180,591,800
10 Day Avg. Volume138,367
30 Day Avg. Volume387,860
Financial Highlights & Ratios
PEG Ratio-0.11
Price to Book (P/B)0.74
Price to Sales (P/S)1.09
P/FCF Ratio9.12
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)AU$60.00M
Bulls Say, Bears Say
Bulls Say
Low Leverage / Strong Capital StructureMinimal financial leverage (debt/equity ~0.018) provides durable financial flexibility. With low interest obligations the company can fund R&D, support product development, or pursue selective M&A without stressing cash flow, improving resilience through cycles.
Recurring Subscription Revenue ModelA subscription and maintenance-focused business creates predictable, recurring revenue and higher customer lifetime value. This structural model supports steady cash inflows, facilitates upsells and renewals, and increases visibility for medium-term planning and margin leverage.
Very High Gross Profit MarginsExtremely high gross margins are typical of software licensing and indicate scalable economics. With low incremental cost of software distribution, the company can invest more in sales and R&D while preserving operating leverage, supporting sustainable operating profitability over time.
Bears Say
Declining Revenue GrowthNegative top-line growth reduces the firm’s ability to absorb fixed costs and limits operating leverage benefits. Sustained revenue contraction can reflect competitive pressures, product-market fit issues, or customer churn, constraining long-term reinvestment capacity and strategic options.
Eroding Profitability And ReturnsSharp declines in ROE and net margins indicate weakening ability to convert revenue into shareholder value. This reduces internal capital generation, makes funding growth more costly, and signals rising competitive or cost pressures that could persist absent structural change.
Weakened Free Cash Flow GenerationA notable drop in free cash flow and low operating cash-to-net-income ratio signal weaker cash conversion. Reduced FCF limits capacity to fund dividends, R&D, or acquisitions internally, increasing vulnerability to funding shocks and reducing margin for strategic investments.
Integrated Research Limited News
IRI FAQ
What was Integrated Research Limited’s price range in the past 12 months?
Integrated Research Limited lowest share price was AU$0.27 and its highest was AU$0.51 in the past 12 months.
What is Integrated Research Limited’s market cap?
Integrated Research Limited’s market cap is AU$52.37M.
When is Integrated Research Limited’s upcoming earnings report date?
Integrated Research Limited’s upcoming earnings report date is Aug 19, 2026 which is in 70 days.
How were Integrated Research Limited’s earnings last quarter?
Integrated Research Limited released its earnings results on Feb 25, 2026. The company reported -AU$0.85 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.85.
Is Integrated Research Limited overvalued?
According to Wall Street analysts Integrated Research Limited’s price is currently Overvalued.
Does Integrated Research Limited pay dividends?
Integrated Research Limited pays a Annually dividend of AU$0.02 which represents an annual dividend yield of 5.97%. See more information on Integrated Research Limited dividends here
What is Integrated Research Limited’s EPS estimate?
Integrated Research Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Integrated Research Limited have?
Integrated Research Limited has 180,591,800 shares outstanding.
What happened to Integrated Research Limited’s price movement after its last earnings report?
Integrated Research Limited reported an EPS of -AU$0.85 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -9.375%.
Which hedge fund is a major shareholder of Integrated Research Limited?
Currently, no hedge funds are holding shares in AU:IRI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Integrated Research Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-35.27%
12-Months-Change
Fundamentals
Return on Equity
7.40%
Trailing 12-Months
Asset Growth
5.13%
Trailing 12-Months
Company Description
Integrated Research Limited
Integrated Research Limited (IRI.AX), an Australian company founded in North Sydney in 1988, specializes in developing, deploying, and selling computer software for managing critical IT systems. Their solutions address business-critical computing, unified communication, and payment networks. The company's flagship product, Prognosis, is a comprehensive software suite engineered to provide management and technical teams with detailed operational insight into platforms such as HP NonStop, distributed system servers, unified communications environments, payment infrastructures, and core business applications. Beyond software, they also deliver testing, maintenance, and professional services, including a Software-as-a-Service (SaaS) option. Integrated Research operates globally, reaching clients in approximately 60 countries through direct sales offices in the United States, the United Kingdom, Germany, Singapore, and Australia, complemented by a broad international channel-driven distribution network. Their diverse customer base includes financial institutions like stock exchanges, banks, and credit card companies, alongside telecommunications carriers, service providers, and manufacturers.
IRI Company Deck
IRI Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presents a mixed picture: meaningful near-term financial headwinds driven by a large one-off expected credit loss and continued churn in core product lines caused profitability to turn negative and pro forma revenue to decline. Offsetting this, IR has a strong cash position (no debt), improved operating cash flow, important product launches (Iris, Elevate), a significant deployment with a top-10 U.S. bank, and a clear product-led growth roadmap including an IR Labs MVP planned for calendar 2026. Management expects higher investment in H2 to fund growth. Overall, strategic product progress and balance-sheet strength are positives, while earnings, renewals volatility and near-term expense increases are material negatives — yielding a balanced outlook.View all AU:IRI earnings summariesTechnical Analysis
Hansen Technologies Limited
―
Connexion Telematics Limited
―
archTIS Ltd.
―
Prophecy International Holdings Ltd
―
Dubber Corporation Limited
―
Options Prices
Currently, No data available
---